We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Company Successful with its Strategic Focus on Vaccines and Oncology Trials BERWYN, Pa., Sept. 9 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full-service multinational...
BERWYN, Pa., Aug. 31 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for...
WAYNE, Pa., Aug. 27 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for...
WAYNE, Pa., July 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and...
Net Loss Significantly Reduced to $195,220 in First Quarter on Cost Cutting WAYNE, Pa., May 19 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational...
WAYNE, Pa., May 18 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational contract research organization (CRO) that provides design, development, and...
WAYNE, Pa., May 7 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and...
WAYNE, Pa., Oct. 6 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for...
WAYNE, Pa., Oct. 1 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ: ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions